Lisa K. Kunkle - 15 Nov 2021 Form 4 Insider Report for AVIENT CORP (AVNT)

Signature
/s/ Lisa K. Kunkle
Issuer symbol
AVNT
Transactions as of
15 Nov 2021
Net transactions value
-$1,140,024
Form type
4
Filing time
17 Nov 2021, 15:30:06 UTC
Next filing
15 Feb 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVNT Common Stock Options Exercise $240,032 +10,400 +15% $23.08 80,010 15 Nov 2021 Direct
transaction AVNT Common Stock Disposed to Issuer $356,527 -5,984 -7.5% $59.58 74,026 15 Nov 2021 Direct
transaction AVNT Common Stock Options Exercise $248,997 +7,100 +9.6% $35.07 81,126 15 Nov 2021 Direct
transaction AVNT Common Stock Disposed to Issuer $326,260 -5,476 -6.7% $59.58 75,650 15 Nov 2021 Direct
transaction AVNT Common Stock Options Exercise $325,295 +8,500 +11% $38.27 84,150 15 Nov 2021 Direct
transaction AVNT Common Stock Disposed to Issuer $405,680 -6,809 -8.1% $59.58 77,341 15 Nov 2021 Direct
transaction AVNT Common Stock Options Exercise $287,270 +11,500 +15% $24.98 88,841 15 Nov 2021 Direct
transaction AVNT Common Stock Disposed to Issuer $463,771 -7,784 -8.8% $59.58 81,057 15 Nov 2021 Direct
transaction AVNT Common Stock Sale $689,381 -11,447 -14% $60.22 69,610 16 Nov 2021 Direct F1
holding AVNT Common Stock 1,986 15 Nov 2021 Savings Plan Trust F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVNT Stock Appreciation Rights Options Exercise $0 -10,400 -100% $0.000000* 0 15 Nov 2021 Common Stock 10,400 $23.08 Direct F3
transaction AVNT Stock Appreciation Rights Options Exercise $0 -7,100 -100% $0.000000* 0 15 Nov 2021 Common Stock 7,100 $35.07 Direct F4
transaction AVNT Stock Appreciation Rights Options Exercise $0 -8,500 -100% $0.000000* 0 15 Nov 2021 Common Stock 8,500 $38.27 Direct F5
transaction AVNT Stock Appreciation Rights Options Exercise $0 -11,500 -100% $0.000000* 0 15 Nov 2021 Common Stock 11,500 $24.98 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale price is a weighted average for the sale transactions. The sales prices range from a low of $59.44 per share to a high of $60.84. Full information regarding the number of shares sold at each separate price is available upon request by the Commission staff, Avient Corporation or a security holder of Avient Corporation.
F2 The information in this report is based on a Avient Retirement Savings Plan statement as of November 15, 2021.
F3 SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $23.08 per share and no more than one-third of the grant can vest per year during the first three years.
F4 SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $35.07 per share and no more than one-third of the grant can vest per year during the first three years.
F5 SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $38.27 per share and no more than one-third of the grant can vest per year during the first three years.
F6 SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $24.98 per share and no more than one-third of the grant can vest per year during the first three years.